InvestorsHub Logo
Followers 5
Posts 1109
Boards Moderated 0
Alias Born 05/02/2014

Re: None

Monday, 10/23/2017 6:51:29 AM

Monday, October 23, 2017 6:51:29 AM

Post# of 140468
Todd Pope says to temper the enthusiasm for Senhance:

https://www.medtechy.com/the-ticker/articles/2017/whats-next-for-transenterix-after-senhances-fda-approval

Interesting read. I think he is laying the groundwork for imminent disappointment for Senhance sales.